Helicobacter pylori: From infection to cure

Canadian Journal of Gastroenterology

Volumn 10, Issue 3, 1996, Pages 167-172

  Thomson, A B R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adenocarcinoma; Eradication; Helicobacter pylori; Mucosa associated lymphoid tissue (MALT) lymphomas; Peptic ulcer disease

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; STOMACH SECRETION INHIBITOR;

CONFERENCE PAPER; DUODENUM ULCER; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; PRIORITY JOURNAL; STOMACH ULCER;

EID: 0029843949     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1996/640239     Document Type: Conference Paper

References (64)

1. Sipponen P, Kosunen TU, Heinonen OP, Samloff IM, Siurala M. Rate of H pylori infection in different birth cohorts. Gut 1995;37:A11.
2. Kohl H, Wolters U, Peitz U, et al. Causative role of Helicobacter pylori in upper gastrointestinal bleeding. GUT 1995;37:A28.
3. Broutet N, Cantet F, Lamouliatte H, Forestier S, Megraud F. Seroprevalence of Helicobacter pylori infection among gastroenterologists in France. Gut 1995;37:A78.
4. Beales I, Crabtree JE, Covacci A, Calam J. Antibodies to CAG A protein in patients with H pylori infection and atrophic gastritis. Gut 1995;37:A37.
5. Akopyants NS, Kersulyte D, Berg DE. CAGII, a new multigene locus associated with virulence in Helicobacter pylon. Gut 1995;37:A1.
6. Atherton JC, Tham KT, Peek RM, Blaser MJ, Cover TL Specific Helicobacter pylon vacA genotypes are associated with presence of duodenal and gastric ulceration, and degree of gastric inflammation. Gut 1995;37:A3.
7. Nilius M, Sienla K, Schuppert U, Sauerbruch T, Malfertheiner P. Helicobacter pylori strain variability in adhesion, cytotoxicity and IL-8 release. Gut 1995;37:A3.
8. Perez-Perez GI, Thiberge JM, Labigne A, Blaser MJ. Relationship between the immune response to HSPA and clinical features in Helicobacter pylori-infected patients. Gut 1995;37:A79.
9. Voland P, Melchers K, Schafer KP, Steinhilber W. Regulation of gene expression by pH and urea in Helicobacter pylori. Gut 1995;37:A2.
10. Avunduk C, Navab F, Hampf F, Coughlin B. Evaluation of large gastric folds in patients with Helicobacter pylori infection by endoscopic ultrasound before and after antimicrobial therapy. Gut 1995;37:A38.
11. Valle J, Kekki M, Sipponen P, Siurala M. The natural history of Helicobacter pylon gastritis: a 30-year histologic follow-up study. Gut 1995;37:A69.
12. Bode G, Mauch F. Ultrastructural evidence for the destruction of gastric epithelial tight junctions by Helicobacter pylori. Gut 1995;7:A73.
13. Rieder G, Hatz RA, Stolte M, Enders G. mRNA transcript for inflammatory mediators in H pylori-associated gastritis. Gut 1995;37:A73.
14. Harris AW, Walker MM, Waller JM, Misiewicz JJ, Baron JH. Parietal cells in the duodenal bulb are more common in H pylon negative patients with duodenal ulcer. Gut 1995;7:A73.
15. Gillen D, El-Omar E, McColl KEL. Parietal cell sensitivity to gastrin distinguishes H pylori infected DU patients from infected healthy volunteers. Gut 1995;37:A8.
16. Hurlimann S, Dur S, Schwab P, et al. Pentagastrin stimulated gastric acid secretion and postprandial gastrin profile in Helicobacter pylori (HP) positive and negative healthy volunteers. Gut 1995;37:A9.
17. Hatz RA, Kopp R, Lehn N, et al. Direct enhancement of gastrin release by H pylori water soluble proteins. Gut 1995;37:A9.
18. Gibbons AH, Legon S, Calam J. H pylon alters the changes in somatostatin and gastrin mRNAs induced by infusion of gastrin releasing peptide. Gut 1995;37:A9.
19. Tham TCK, Chen L, Dennison N, et al. Antral somatostatin cell density and Helicobacter pylori in man. Gut 1995;37:A9.
20. Gibbons AH, Legon S, Calam J. Effect of H pylori on expression of somatostatin mRNA in the gastric antrum and corpus. Gut 1995;37:A83.
21. Isakov VA, Aruin LI, Zverkov IV. Hypergastrinemia is associated with Helicobacter pylori infective load in duodenal ulcer patients. Gut 1995;37:A29.
22. Le Roux PH, Harris AW, Walker MM, Misiewicz JJ, Baron JH. Gastric acid output, bacterial load and gastritis in Helicobacter pylori (Hp) positive patients with duodenal ulcer (DU). Gut 1995;37:A73.
23. Gisbert JP, Boixeda D, Vila T, de Rafael L, Alvarex I, Martin de Argila C. Basal and stimulated gastrin levels and gastric acid output five months after therapy for H pylori eradication in duodenal ulcer patients. Gut 1995;37:A30.
24. Lambert JR, Midolo P, Prichard PJ, Savage J, Bampton P. Helicobacter pylori infection causes increased hypergastrinaemia during omeprazole therapy. Gut 1995;37:A59.
25. Savio A, Granzin G, Wotherspoon AC, et al. Long-term effect of anti-Helicobacter pylori therapy on gastric MALT lymphoma. Histological and molecular evaluation of 15 cases. Gut 1995;37:A6.
26. Karameris A, Rokkas T. Evidence for the role of Helicobacter pylori in the pathogenesis of MALT-type lymphomas of the stomach through an autoimmune mechanism. Gut 1995;37:A76.
27. Azuma T, Hirai NE, Ito S, Kato T, Kohli Y, Kuriyama M. Host's genetic analysis in patients with atrophic gastritis or gastric carcinoma harboring Helicobacter pylori. Gut 1995;37:A7.
28. Graham DY, Malaty FIM, Glober G, et al. Prevalence of gastric atrophy, the precursor lesion of gastric carcinoma, is independent of the prevalence of Hp infection: evidence that while Hp infection may be the major determining factor for gastric cancer it is not for gastric atrophy. Gut 1995;37:A7.
29. Buck FJ, Doidge C, Lee A. Therapeutic immunisation - the future for helicobacter treatment? Gut 1995;37:A93.
30. Kleanthous H, Ermak T, Pappo J, Lee C, Monath T. Oral immunization with recombinant Helicobacter pylori urease apoenzyme in the treatment of helicobacter infection. Gut 1995;37:A94.
31. Siepman N, Green R, Aynilian G. A comparison of biopsy specimens from the antrum and corpus for culture of H pylori. Gut 1995;37:A14.
32. Karttunen TJ, El-Zaatari FAK, Genta RM, Yoffe B, Graham DY. Detection of Helicobacter pylori in gastric biopsies by in situ hybridization. Gut 1995;37:A59.
33. Karnes WE, Samloff IM Jr, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
34. 13carbon urea breath test to diagnose Helicobacter pylori (H pylori) infection. Gut 1995;37:A12.
35. 13C-urea breath test (UBT) for the diagnosis of H pylori infection. Gut 1995;37:A53.
36. 14C urea breath test for diagnosis of Helicobacter pylori infection. Gut 1995;37:A53.
37. Prasad VM, Sharma TK, Cutler AF. Quantitative noninvasive testing for H pylori does not predict gastroduodenal ulcer disease. Gut 1995;37:A13.
38. 13C-urea breath test for early assessment of Helicobacter pylori eradication. Gut 1995;37:A61.
39. Yousfi MM, El-Zimaity H, Cole RA, Genta RM, Graham DY. Commercially available rapid urease tests vary in efficacy for detecting Helicobacter pylori infection. Gut 1995;37:A13.
40. Lahaie RG, Ricard N. Validation of Helisal whole blood, serum and saliva tests for the non-invasive diagnosis of H pylori infection. Gut 1995;37:A13.
41. Luzza F, Maletta M, Imeneo M, Biancone L, Pallone F. Salivary specific IgG in the diagnosis of Helicobacter pylori infection in dyspeptic patients. Gut 1995;37:A52.
42. Yapp T, Kapur K, Thomas GAO, Swift J, Pugh S. Validation of the Helisal rapid hole blood test for the detection of IgG antibodies to H pylori. Gut 1995;37:A56.
43. Moayyedi P, Carter AM, Heppell RM, Catto AJ, Grant P, Axon ATR. Validation of a rapid whole blood test for the diagnosis of Helicobacter pylori infection. Gut 1995;37:A53.
44. Seppala K, Sipponen P, Nuutinen H, Kosunen TU. Diagnosis of H pylori infection in peptic gastric ulcer. How to do it properly? Gut 1995;37:A58.
45. Karttunen TJ, Niemela S, Kerola T. Blood leukocytes in H pylori infection. Gut 1995;37:A36.
46. Hopkins RJ, Girardi LS, Turney EA. Helicobacter pylori eradication as a surrogate for reduced peptic ulcer recurrence: A literature-based metal-analysis. Gut 1995;37:A46.
47. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. The Mach 1 study: optimal one-week treatment for H pylori defined? Gut 1995;37:A4.
48. Labenz J, Adamek RJ, Idstrom JP, Peitz U, Tillenburg B, Borsch G. Duodenal ulcer healing and Helicobacter pylori eradication by one-week low-dose triple therapy with omeprazole, clarithromycin and metronidazole. Gut 1995;37:A41.
49. Buckely M, Xia HX, Hyde D, O'Moraine C. A cost-effective, European approach to H pylori eradication. Gut 195;37:A91.
50. Delchier JC, Elamine I, Goldfain D, Chaussade S, Mancini L, Idstrom JP. Comparison of omeprazole (OM) + Amoxicillin (AM) versus OM + clarithromycin (CLA) in the eradication of Helicobacter pylori (Hp) - results from a randomized study involving 120 patients. Gut 1995;37:A55.
51. Lamouliatte H, Cayla R, Forestier S, et al. Dual therapy versus triple therapy: high dose of lansoprazole plus amoxicillin in combination or not with clarithromycin for Helicobacter pylori infection. Gut 1995;37:A92.
52. Sung JY, Ling TKW, Suen R, Leung VKS, Ng EKW, Chung SCS. Amoxicillin plus omeprazole versus triple therapy, for the eradication of H pylori and healing of duodenal ulcers. Gut 1995;37:A6.
53. Pounder RE, Bailey R, Louw JA, et al. GR122311X (ranitidine bismuth citrate) with clarithromycin for the eradication of Helicobacter pylori. Gut 1995;37:A42.
54. Peterson WL, Sontag SJ, Ciociola AA, Sykes DL, McSorley DJ, Webb DD and the H pylori Ulcer Group. Ranitidine bismuth citrate plus clarithromycin is effective in the eradication of Helicobacter pylori and prevention of duodenal ulcer relapse. Gut 1995;37:A5.
55. Bardhan KD, Dallaire C, Eisold H, Duggan AE. The treatment of duodenal ulcer with GR122311X (ranitidine bismuth citrate) and clarithromycin. Gut 1995;37:A5.
56. O'Morain C, Schulz TB, Tam C-Y, Dixon MF, Quirke P, Duggan AE. GR122311X (ranitidine bismuth citrate) with amoxycillin for the eradication of Helicobacter pylori. Gut 1995;37:A42.
57. Butruk E, Ching CK, Schutze K, Duggan AE. The treatment of duodenal ulcer with GR122311X (ranitidine bismuth citrate) and amoxycillin. Gut 1995;37:A42.
58. Kusstatscher S, Dal Bo N, Ferrana M, et al. Cigarette smoking and gastritis activity are predicting factors of Helicobacter pylori eradication rate. Gut 1995;37:A47.
59. DeBartolo M, Reltmayer R, Olson C, Edmonds A. Effect of smoking on H pylori (HP) eradication and duodenal ulcer (DU) recurrence in patients receiving dual therapy with clarithromycin (CL) in combination with omeprazole (OM). Gut 1995;37:A85.
60. Calya R, Zerbib F, Talbi P, Megraud F, Lamouliatte H. Pre- and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995;37:A55.
61. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA. Effects of antibiotic-resistance on clarithromycin-combined triple therapy for Helicobacter pylon. Gut 1995;37:A55.
62. Lowy A, Dworkin B, Van Horn K, Schwan SM, Lebovics E, Bennett Clark S. Clinical and endoscopic characteristics of metronidazole resistant Helicobacter pylori. Gut 1995;37:A72.
63. Labenz J, Tillenburg B, Peitz U, Sollbohmer M, Stolte M, Borsch G. Long-term clinical course of ulcer disease and incidence of reflux esophagitis in a large cohort of duodenal ulcer patients followed after eradication of Helicobacter pylori. Gut 1995;37:A6.
64. Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-raising effects of omeprazole in duodenal ulcer patients. Gut 1995;37:A8.